PART I The following discussion of our business contains forward-looking statements that involve risks and uncertainties (see the section entitled Forward-Looking Statements herein). Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those factors set forth under Risk Factors and elsewhere in this Form 10-K. Overview We are a life sciences company that develops, manufactures, and markets bioproduction pr...
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001628280-26-012294 | EDGAR | 56K words |
| 2025-03-03 | 2024-12-31 | 0001628280-25-009511 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001628280-24-008061 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001437749-23-008875 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001437749-22-007869 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001437749-21-007867 | EDGAR | — |
| 2020-05-15 | 2019-12-31 | 0001437749-20-011046 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001628280-25-050190 | EDGAR | 27K words |
| 2025-08-07 | 2025-06-30 | 0000834365-25-000016 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023833 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001628280-24-047178 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001628280-24-036470 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001628280-24-022690 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001628280-23-038259 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001628280-23-028419 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001437749-23-013777 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001437749-22-026629 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001437749-22-019625 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001437749-22-011722 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-02 | 0001628280-26-013277 | EDGAR | 4K words |
| 2026-02-26 | 0001628280-26-012264 | EDGAR | — |
| 2026-01-12 | 0001628280-26-001767 | EDGAR | — |
| 2026-01-09 | 0001628280-26-001649 | EDGAR | — |
| 2025-11-17 | 0001628280-25-052479 | EDGAR | — |
| 2025-11-06 | 0001628280-25-050163 | EDGAR | — |
| 2025-08-21 | 0000834365-25-000018 | EDGAR | — |
| 2025-08-07 | 0000834365-25-000014 | EDGAR | — |
| 2025-05-08 | 0001628280-25-023798 | EDGAR | — |
| 2025-03-24 | 0001628280-25-014541 | EDGAR | — |
121 total filings indexed. 92 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000834365 |
| Ticker | BLFS |
| Exchange | Nasdaq |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | DE |
| Website | https://www.biolifesolutions.com |
| Listed | 1989-11-22 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report